EAST-ASIA PHARMACEUTICAL: The raw material drug Cefotiam has obtained the raw material drug registration certificate in South Korea
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, EAST-ASIA PHARMACEUTICAL announced that its wholly-owned subsidiary, Zhejiang Dongbang Pharmaceutical Co., Ltd., has recently received the active pharmaceutical ingredient registration certificate from the Korean Ministry of Food and Drug Safety (Korean MFDS). The product name is Cefotaxime Probenecid, which is a third-generation cephalosporin antibiotic used to treat infections of the respiratory tract, urinary system, biliary tract, and skin soft tissues caused by sensitive bacteria
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments